【直播】【RSC英国皇家化学会】RSC Pharmaceutics 专场

学术   2024-10-30 00:02   安徽  



2024 年 RSC “编辑面对面” 线上研讨会持续进行中!10月31日下周四将迎来 “编辑面对面” 系列线上研讨会的第八期。我们特邀 RSC Pharmaceutics 主编 Yvonne Perrie 教授 (University of Strathclyde) ,以及副主编刘潇璇教授 (中国药科大学), 为大家分享最新科研进展与成果。

聆听期刊权威编委会成员的最新科研进展,获取期刊咨询,了解文章发表要领,且有机会与编辑们互动交流,就在10月31日下午15: 00点!

蔻享直播


主讲嘉宾


Yvonne Perrie 教授

University of Strathclyde, UK

RSC Pharmaceutics 主编

报告题目


Formulation and Manufacturing considerations for Lipid nanoparticles

My current position is Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland. In 1998 I gained my PhD from the University of London investigating the role of liposomes for DNA vaccines and drug delivery. I then worked within a newly established Drug Delivery Company (Lipoxen Technologies Ltd) for two years, developing their liposome drug delivery platform technology before moving into Academia to set up my own research group. I joined Aston University in 2000 and was appointed Professor in Drug Delivery in 2007. In 2016, I moved to the University of Strathclyde as Professor in Drug Delivery as part of the Global Talent Appointment Programme where I continue to develop and advance my research strategies.
My research is multi-disciplinary and focuses on developing drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. I am an internationally recognised expert in the field of liposomes and particulate drug delivery research. My laboratory is fully equipped to manufacture and analyze a wide range of nanoparticles, including a suite of microfluidic systems that will provide the underpinning support for this project. I maintain a steady funding stream to support my research team through various sources, including Government Research Councils, European Framework Funding, Industrial Partners, and Charities.
下滑查看


刘潇璇 教授

中国药科大学

RSC Pharmaceutics 副主编

报告题目


Amphiphilic dendrimer based self-assembling nanosystems as an adaptive drug delivery platform for nucleic acid therapeutics

刘潇璇,中国药科大学多靶标天然药物全国重点实验室教授,入选国家海外高层次青年人才、江苏省特聘教授。研究工作聚焦于开发基于树形分子的新型自组装纳米材料,并以此构筑安全高效的核酸药物载体,用于癌症等难治性疾病的治疗。研究成果发表在 PNAS,Nat. Commun. J. Am. Chem. Soc.,Angew. Chem. In. Ed. 等学术期刊上。作为主持人或课题负责人先后承担国家重点研发计划、国家自然科学基金等多项科研项目。担任中国复合材料学会生物医用复合材料分会委员、中国生物物理学会纳米生物学分会委员、中国药学会药剂专业委员会青年委员,英国皇家化学会药剂学期刊 RSC Pharmaceutics 副主编,《中国药科大学学报》、《亚洲药物制剂科学》等期刊编委。

 下滑查看


声明:此文是出于传递更多信息之目的。部分图片、资料来源于网络,版权归原作者所有,如有侵权请联系后台删除。

往期推荐:





【RSC英国皇家化学会】𝘙𝘚𝘊 𝘔𝘦𝘤𝘩𝘢𝘯𝘰𝘤𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺 专场


【RSC英国皇家化学会】𝘙𝘚𝘊 𝘊𝘩𝘦𝘮𝘪𝘤𝘢𝘭 𝘉𝘪𝘰𝘭𝘰𝘨𝘺专场


【RSC英国皇家化学会】中国化学会–英国皇家化学会青年化学家峰会


【RSC英国皇家化学会】Energy Advances 专场


【RSC英国皇家化学会】RSC Sustainability 专场


点击“阅读原文

蔻享学术
传播科学、共享科学、服务科学
 最新文章